PRECISION MEDICINE THROUGH NOVEL COVALENCY
Dead / Abandoned — Abandoned — failure to respond (as of 11 Jul 2024)
What this means for you
This application is over — abandoned 28 Jun 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97897337
- Mark type
- Stylized text
- Filed
- 19 Apr 2023
- Abandoned
- 28 Jun 2024
- Attorney of record
- Kongsik Kim
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and biopharmaceutical preparations for the treatment and prevention of cancers, auto-immune diseases, fibrosis, neurological diseases, and metabolic diseases for therapeutical applications
Owner
- Bridge Biotherapeutics Inc., Newton, MA, US
Prosecution history
- 11 Jul 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 11 Jul 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 27 Mar 2024 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 27 Mar 2024 — FINAL REFUSAL E-MAILED
- 27 Mar 2024 — FINAL REFUSAL WRITTEN
- 29 Feb 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 29 Feb 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 29 Feb 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 19 Jan 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 19 Jan 2024 — NON-FINAL ACTION E-MAILED
- 19 Jan 2024 — NON-FINAL ACTION WRITTEN
- 16 Jan 2024 — ASSIGNED TO EXAMINER
- 16 May 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 22 Apr 2023 — NEW APPLICATION ENTERED